MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 4DP2CA280626-02
Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genes
National Institutes of Health
Grant: 5P30CA138313-09
Medical University of South Carolina - Cancer Center Support Grant
National Institutes of Health
Grant: 1K99CA207729-01A1
Copy Number Alterations in Low Mutation Cancer
NCI NIH HHS
Grant: R00 CA207729
NCI NIH HHS
Grant: K99 CA207729
NIGMS NIH HHS
Grant: T32 GM132055
NIGMS NIH HHS
Grant: P20 GM103499
NIGMS NIH HHS
Grant: R35 GM119512
NCI NIH HHS
Grant: P30 CA138313
NCI NIH HHS
Grant: DP2 CA280626
Fields of Study
Keywords
Sustainable Development Goals